SynthesisBMJ open diabetes research & care2020

SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews.

Shih-Chieh Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.